{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:41:48Z","timestamp":1792662108380,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Senior Research Fellowship"},{"DOI":"10.13039\/100012117","name":"Lady Tata Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections (BSIs) are associated with high mortality, yet predictors of early mortality remain inadequately studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective observational study of patients with CRAB-BSI from July 2021 to December 2023. Patients \u226518\u00a0y of age with CRAB bacteraemia were included. Clinical, microbiological and treatment data were collected. Multivariable logistic regression was performed to identify independent predictors of 7-d mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 154 patients were included. The 7- and 30-d mortality rates were 57.1% and 76.6%, respectively. Common BSI sources included hospital-acquired pneumonia (51.3%) and vascular catheters (29.2%). Only 37% received appropriate empirical therapy. On multivariable analysis, type 2 diabetes mellitus (adjusted odds ratio [aOR] 2.35, p=0.031), inotrope requirement at BSI onset (aOR 3.11 [95% confidence interval 1.28 to 7.56], p=0.013) and higher tigecycline minimum inhibitory concentration in Vitek-2 (aOR 2.50, p=0.040) were independent predictors of early mortality. Vascular catheter\u2013related BSI (aOR 0.25, p=0.003) was associated with lower early mortality. The association between appropriate targeted therapy (aOR 0.21, p=0.001) and mortality was interpreted cautiously because of potential survivor bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early mortality in patients with CRAB-BSI is linked to host factors, severity of illness and antimicrobial resistance. Catheter-associated BSI, likely reflecting the feasibility of source control, was associated with improved outcomes. Appropriate targeted therapy was also associated with survival, which should be interpreted cautiously because of potential survivor bias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag129","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:14:56Z","timestamp":1792660496000},"source":"Crossref","is-referenced-by-count":0,"title":["Mortality outcomes and their predictors in patients with carbapenem-resistant\n                    <i>Acinetobacter baumannii<\/i>\n                    bacteraemia: a prospective cohort study from South India"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2614-5393","authenticated-orcid":false,"given":"Manasa","family":"Tantry","sequence":"first","affiliation":[{"name":"Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-2836","authenticated-orcid":false,"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-6148","authenticated-orcid":false,"given":"Vishal","family":"Shanbhag","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-5332","authenticated-orcid":false,"given":"Shwethapriya","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-5353","authenticated-orcid":false,"given":"Muralidhar","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-1143","authenticated-orcid":false,"given":"Chiranjay","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7561-4435","authenticated-orcid":false,"given":"Vandana Kalwaje","family":"Eshwara","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education , Manipal ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102205145476600_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2026102205145476600_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jgar.2024.06.010","article-title":"Risk factors for mortality in Acinetobacter b aumannii bloodstream infections and development of a predictive mortality model","volume":"38","author":"Corcione","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"2026102205145476600_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jinf.2019.05.017","article-title":"Bloodstream infections caused by carbapenem-resistant Acinetobacter b aumannii: clinical features, therapy and outcome from a multicenter study","volume":"79","author":"Russo","year":"2019","journal-title":"J Infect"},{"key":"2026102205145476600_bib4","doi-asserted-by":"crossref","first-page":"115229","DOI":"10.1016\/j.diagmicrobio.2020.115229","article-title":"Risk factors and outcomes of bloodstream infections caused by Acinetobacter b aumannii: a case\u2013control study","volume":"99","author":"Gu","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026102205145476600_bib5","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026102205145476600_bib6","doi-asserted-by":"crossref","first-page":"e14937","DOI":"10.1097\/MD.0000000000014937","article-title":"Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter b aumannii bacteremia","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2026102205145476600_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jmii.2023.11.001","article-title":"Clinical and molecular predictors of mortality in patients with carbapenem-resistant Acinetobacter b aumannii bacteremia: a retrospective cohort study","volume":"57","author":"Suh","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"2026102205145476600_bib8","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"2026102205145476600_bib9","volume-title":"Performance standards for antimicrobial testing; thirty-third informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2023"},{"key":"2026102205145476600_bib10","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard","author":"Clinical and Laboratory Standards Institute","year":"2015","edition":"10th Edition"},{"key":"2026102205145476600_bib11","article-title":"Tigecycline \u2013 injection products","author":"US Food and Drug Administration"},{"key":"2026102205145476600_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2026102205145476600_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/microorganisms12010213","article-title":"Hospital-acquired pneumonia and ventilator-associated pneumonia: a literature review","volume":"12","author":"Miron","year":"2024","journal-title":"Microorganisms"},{"key":"2026102205145476600_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jgar.2022.08.010","article-title":"Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia","volume":"31","author":"Lee","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"2026102205145476600_bib15","doi-asserted-by":"crossref","first-page":"dlad096","DOI":"10.1093\/jacamr\/dlad096","article-title":"Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization","volume":"5","author":"Cogliati\u00a0Dezza","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205145476600_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/microorganisms8020287","article-title":"Colistin-resistant Acinetobacter b aumannii bacteremia: a serious threat for critically ill patients","volume":"8","author":"Papathanakos","year":"2020","journal-title":"Microorganisms"},{"key":"2026102205145476600_bib17","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2147\/IDR.S408927","article-title":"Assessment of effective antimicrobial regimens and mortality-related risk factors for bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"16","author":"Gu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2026102205145476600_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2026102205145476600_bib19","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2147\/IDR.S169432","article-title":"Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections: cefoperazone-sulbactam associated with resistance and tigecycline increased the mortality","volume":"11","author":"Niu","year":"2018","journal-title":"Infect Drug Resist"},{"key":"2026102205145476600_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag129\/72333429\/trag129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag129\/72333429\/trag129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:15:00Z","timestamp":1792660500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article\/doi\/10.1093\/trstmh\/trag129\/8974604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag129","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"article-number":"trag129"}}